212102
Gay and Bisexual Men′s Willingness to Receive Anal Pap Testing
Alison C. Reed
,
Health Behavior and Health Education, UNC Gillings School of Global Public Health, Chapel Hill, NC
Noel T. Brewer, PhD
,
Health Behavior and Health Education, UNC-Chapel Hill, School of Public Health, Chapel Hill, NC
Jennifer S. Smith, PhD
,
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
Paul L. Reiter, PhD
,
Lineberger Comprehensive Cancer Center, UNC-Chapel Hill, Chapel Hill, NC
Objectives. We sought to characterize the willingness of men who have sex with men (MSM) to receive anal Pap tests, because these men have high rates of anal cancer that may be prevented through regular screening. Methods. We surveyed a national sample of men aged 18-59 who self-identified as gay (n=236) or bisexual (n=70). Results. Few men were willing to receive anal Pap tests not paid for by insurance, but most would accept free screening (31% vs. 83%, McNemar's χ2=158.02, ρ<.001). Willingness to pay for screening was higher among men who reported greater worry about getting anal cancer (OR=1.70, 95%CI=1.06, 2.72), higher perceived likelihood of anal cancer (OR=1.88, 95%CI=1.18, 2.99), and higher income (OR=2.17, 95%CI=1.18, 3.98), in adjusted analyses. Only 33% (17/51) of human immunodeficiency virus (HIV)-positive men, who have the highest risk for anal cancer, had previously received anal Pap tests. Conclusions. Anal cancer screening was highly acceptable to MSM, although cost was a major barrier. Modifiable beliefs associated with anal Pap test acceptability provide targets for future efforts to reduce anal cancer disparities among MSM relative to heterosexual men.
Learning Objectives: 1. Describe gay and bisexual men's awareness, beliefs, and use of anal Pap testing.
2. Identify correlates of gay and bisexual men's willingness to get a future anal Pap test.
3. Identify if beliefs about anal Pap testing and willingness to receive a future test differ by sexual orientation and HIV status.
Keywords: Cancer Screening, Male Health
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I have just completed an MPH, having focused on LGBT populations, and am starting medical school for an MD this fall. I completed this research as part of my MPH degree program at UNC Chapel Hill. I am the first author on our manuscript.
Any relevant financial relationships? Yes
Name of Organization |
Clinical/Research Area |
Type of relationship |
Merck & Co., Inc. |
Research Grant |
Supported in part by research grants from the Merck ISP program and ACS (#MSRG-06-259-01-CPPB). |
ACS |
Research Grant |
Supported in part by research grants from the Merck ISP program and ACS (#MSRG-06-259-01-CPPB). |
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|